Scientists launch Largest-Ever study of rare bladder and genital cancers
NCT ID NCT04923178
First seen Jun 26, 2026 · Last updated Aug 11, 2026 · Updated 7 times
Summary
This study follows 1,100 adults with rare urinary tract cancers, such as unusual bladder, kidney, testicular, or penile cancers. Researchers will collect medical records, blood and tumor samples, and imaging over many years to understand how these cancers grow and respond to treatment. The goal is to fill knowledge gaps and improve care for these often-overlooked cancers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide crucial insights into how rare urinary tract cancers behave, helping doctors develop better treatment guidelines.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test any new therapy, and results may take years to influence patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- Can a Bag-Like device pull bladder tumors out whole?
- A second look: MRI screening may spot hidden prostate cancers
- Can Pre-Surgery chemotherapy outsmart aggressive bladder cancer?
- Can precision protons spare the bowel in prostate cancer?